NASDAQ · Financial Statements

Supernus Pharmaceuticals, Inc. (SUPN) Financial Statements

$42.67 NASDAQ: SUPN Market Cap $2.48B

Supernus Pharmaceuticals, Inc. most recently reported annual revenue of $719.0M, net profit of $-39.0M, revenue has compounded at 6.7% a year over the last five years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20212022202320242025
Revenue$580.0M$667.0M$608.0M$662.0M$719.0M
Operating Profit$86.0M$46.0M$-5.0M$82.0M$-37.0M
Net Profit$53.0M$61.0M$1.0M$74.0M$-39.0M
EPS$0.98$1.04$0.02$1.32$-0.68
Op Margin14.8%6.9%-0.9%12.3%-5.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.7B$1.7B$1.3B$1.4B$1.5B
Total Liabilities$873.0M$816.0M$356.0M$332.0M$391.0M
Cash$203.0M$93.0M$75.0M$69.0M$128.0M
Borrowings$427.0M$445.0M$42.0M$34.0M$41.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$127.0M$117.0M$111.0M$172.0M$47.0M
Investing Cash Flow$-84.0M$-217.0M$268.0M$-191.0M$3.0M
Financing Cash Flow$0$-23.0M$-2.0M$-3.0M$-28.0M
Net Cash Flow$-85.0M$-110.0M$-18.0M$-6.0M$61.0M
Free Cash Flow$125.0M$116.0M$111.0M$171.0M$46.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.21
EV / EBITDA-146.20
FCF Yield0.76%
Quick Ratio1.84
Interest Coverage-48.30
Return 1Y43.68%
Return 3Y53.35%
Return 5Y72.13%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
SUPN Overview SUPN Dividend Run Stock Screener